Further work is required to confirm the role of EBV and of EBI2 and its oxysterol ligands in CFS/ME, and to identify the most practical means to identify patients of the EBI subtype. The gene discussed is GPR183; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.